APA (7th ed.) Citation

Hasford, J., Baccarani, M., Hoffmann, V., Guilhot, J., Saußele, S., Rosti, G., . . . Hehlmann, R. (2011). Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: The EUTOS score. Blood, 118(3), . https://doi.org/10.1182/blood-2010-12-319038

Chicago Style (17th ed.) Citation

Hasford, Joerg, et al. "Predicting Complete Cytogenetic Response and Subsequent Progression-free Survival in 2060 Patients with CML on Imatinib Treatment: The EUTOS Score." Blood 118, no. 3 (2011). https://doi.org/10.1182/blood-2010-12-319038.

MLA (9th ed.) Citation

Hasford, Joerg, et al. "Predicting Complete Cytogenetic Response and Subsequent Progression-free Survival in 2060 Patients with CML on Imatinib Treatment: The EUTOS Score." Blood, vol. 118, no. 3, 2011, https://doi.org/10.1182/blood-2010-12-319038.